1. Home
  2. XRTX vs SGLY Comparison

XRTX vs SGLY Comparison

Compare XRTX & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • SGLY
  • Stock Information
  • Founded
  • XRTX 2011
  • SGLY 2001
  • Country
  • XRTX Canada
  • SGLY United States
  • Employees
  • XRTX N/A
  • SGLY N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • SGLY
  • Sector
  • XRTX Health Care
  • SGLY
  • Exchange
  • XRTX Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • XRTX 3.4M
  • SGLY 4.1M
  • IPO Year
  • XRTX N/A
  • SGLY 2008
  • Fundamental
  • Price
  • XRTX $0.90
  • SGLY $0.99
  • Analyst Decision
  • XRTX
  • SGLY
  • Analyst Count
  • XRTX 0
  • SGLY 0
  • Target Price
  • XRTX N/A
  • SGLY N/A
  • AVG Volume (30 Days)
  • XRTX 88.1K
  • SGLY 14.8K
  • Earning Date
  • XRTX 08-18-2025
  • SGLY 08-26-2025
  • Dividend Yield
  • XRTX N/A
  • SGLY N/A
  • EPS Growth
  • XRTX N/A
  • SGLY N/A
  • EPS
  • XRTX N/A
  • SGLY N/A
  • Revenue
  • XRTX N/A
  • SGLY $2,172,036.00
  • Revenue This Year
  • XRTX N/A
  • SGLY N/A
  • Revenue Next Year
  • XRTX N/A
  • SGLY N/A
  • P/E Ratio
  • XRTX N/A
  • SGLY N/A
  • Revenue Growth
  • XRTX N/A
  • SGLY N/A
  • 52 Week Low
  • XRTX $0.66
  • SGLY $0.54
  • 52 Week High
  • XRTX $2.98
  • SGLY $7.65
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 57.65
  • SGLY 48.70
  • Support Level
  • XRTX $0.73
  • SGLY $0.92
  • Resistance Level
  • XRTX $0.82
  • SGLY $1.14
  • Average True Range (ATR)
  • XRTX 0.07
  • SGLY 0.04
  • MACD
  • XRTX 0.01
  • SGLY -0.01
  • Stochastic Oscillator
  • XRTX 90.96
  • SGLY 36.84

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: